Free Trial

Spartan Fund Management Inc. Takes Position in Viemed Healthcare, Inc. (NASDAQ:VMD)

Spartan Fund Management Inc. bought a new stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 125,240 shares of the company's stock, valued at approximately $983,000. Spartan Fund Management Inc. owned approximately 0.33% of Viemed Healthcare at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. AJOVista LLC acquired a new position in Viemed Healthcare in the fourth quarter worth about $42,000. State of New Jersey Common Pension Fund D bought a new position in Viemed Healthcare in the fourth quarter worth about $189,000. Bailard Inc. acquired a new position in Viemed Healthcare in the fourth quarter valued at approximately $251,000. Violich Capital Management Inc. acquired a new position in shares of Viemed Healthcare during the fourth quarter valued at $177,000. Finally, Ulland Investment Advisors LLC increased its stake in shares of Viemed Healthcare by 63.8% in the fourth quarter. Ulland Investment Advisors LLC now owns 20,675 shares of the company's stock valued at $162,000 after purchasing an additional 8,050 shares during the period. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

Viemed Healthcare Price Performance

VMD stock traded up $0.01 during trading on Friday, hitting $7.15. The company had a trading volume of 300,697 shares, compared to its average volume of 109,792. The business has a 50 day moving average of $8.66 and a 200 day moving average of $8.13. The company has a current ratio of 1.28, a quick ratio of 1.05 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $277.37 million, a price-to-earnings ratio of 27.48 and a beta of 1.53. Viemed Healthcare, Inc. has a fifty-two week low of $5.90 and a fifty-two week high of $11.08.


Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, March 6th. The company reported $0.09 EPS for the quarter. Viemed Healthcare had a net margin of 5.32% and a return on equity of 9.32%. The company had revenue of $50.74 million during the quarter.

About Viemed Healthcare

(Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Featured Articles

Institutional Ownership by Quarter for Viemed Healthcare (NASDAQ:VMD)

→ The 7th Trillion Dollar Company? (From The Oxford Club) (Ad)

Should you invest $1,000 in Viemed Healthcare right now?

Before you consider Viemed Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.

While Viemed Healthcare currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: